Ulcerative colitis treatment drug Omvoh, from Eli Lilly, was linked to sustained clinical remission after 4 years, according to new trial data. Image credit: Plexi Images/GHI/UCG/Universal Images ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Spyre Therapeutics Inc. (NASDAQ:SYRE) is one of the 10 Stocks With Monster Returns. Spyre Therapeutics grew its share prices ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Spyre Therapeutics Inc. SYRE shares are up on Monday following the announcement of positive results from the Phase 2 SKYLINE ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

Spyre Therapeutics stock soared to a four-year high Monday on positive 12-week test results for its ulcerative colitis ...

Tremfya is a brand-name medication used to treat moderate to severe ulcerative colitis in adults by targeting a protein that reduces inflammation in the large intestine. Treatment with Tremfya ...

The great news is that today, there are more effective and diverse treatment options for IBD than ever before, thanks to recent advances in medications and therapies. With so many choices available, ...

If you have ulcerative colitis (UC), your first line of treatment will likely be medication. But even with medication, sometimes symptoms continue to flare, tanking your quality of life along the way.

Receiving a new health diagnosis can feel like the world has shifted beneath your feet. When that diagnosis is ulcerative colitis (UC), the news can bring a mix of emotions—perhaps some relief from ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...